BKKT

Strengthened commercial organization positions Bakkt to accelerate adoption across new industries and geographies, with sector-specific product launches expected to materially increase transaction volumes in 2027 Strengthened commercial organization positions Bakkt to accelerate adoption across new industries and geographies, with sector-specific product launches expected to materially increase transaction volumes in 2027

Shares of Bakkt Holdings Inc. (NYSE:BKKT) are trading higher Friday morning, riding a wave of renewed momentum across crypto-linked equities.

ATLANTA, Aug. 17, 2026 (GLOBE NEWSWIRE) -- Bakkt, Inc. (NYSE: BKKT) (“Bakkt” or the “Company”) today announced the appointment of Matt White as Chief Financial Officer, effective August 17, 2026. Matt joins Bakkt as the Company enters its next phase of global growth, with an expanding focus on technology-enabled financial infrastructure, AI and disciplined capital allocation.

Bakkt NYSE: BKKT reported second-quarter GAAP net income of $80.8 million, or $1.94 per diluted share, while management outlined plans to scale transaction activity across its markets, financial-agent and international strategic-investment businesses.

Bakkt, Inc. (BKKT) Q2 2026 Earnings Call Transcript

ATLANTA, July 27, 2026 (GLOBE NEWSWIRE) -- Bakkt, Inc. ("Bakkt" or the "Company") (NYSE:BKKT) today announced that it will release its second quarter 2026 financial results after market close on Monday, August 10, 2026. Management will host a conference call at 5:30 PM EDT on the same day to review the results and answer questions.

NEW YORK, June 11, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Bakkt, Inc. ("Bakkt" or the "Company") (NYSE: BKKT).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.

NEW YORK, June 09, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Bakkt, Inc. (“Bakkt” or the “Company”) (NYSE: BKKT).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com  or 646-581-9980, ext. 7980.

NEW YORK, June 4, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Bakkt, Inc. ("Bakkt" or the "Company") (NYSE: BKKT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.

ATLANTA, June 04, 2026 (GLOBE NEWSWIRE) -- Bakkt, Inc. (“Bakkt,” or “the Company”) (NYSE: BKKT) today announced that it has received the required Indian regulatory approvals in connection with its previously disclosed strategic investment in Transchem Limited (BSE: 500422) (“Transchem”). Following receipt of such approvals, Transchem has completed the allotment of 47,500,000 warrants to Bakkt, for which Bakkt paid approximately $9.4 million, representing 25% of the total subscription amount.